Axsome Therapeutics Inc (NASDAQ:AXSM)
| 74.32 Delayed Data As of 3:59pm ET |  -0.20 / -0.27%Today’s Change | 20.63 Today|||52-Week Range 82.00 | -3.64% Year-to-Date |
Latest AXSM News | Press Releases
| The Ultimate Growth Stocks to Buy With $300 Right Now Jan 29 / MotleyFool.com - Paid Partner Content | 2 Promising New Growth Stocks to Watch in 2023 Jan 23 / MotleyFool.com - Paid Partner Content |
Today’s Trading
| Previous close | 74.52 |
| Today’s open | 73.31 |
| Day’s range | 72.90 - 76.65 |
| Volume | 34,885 |
| Average volume (3 months) | 1,300,741 |
| Market cap | $3.1B |
Data as of 3:59pm ET, 02/02/2023
Growth & Valuation
| Earnings growth (last year) | -25.34% |
| Earnings growth (this year) | -24.76% |
| Earnings growth (next 5 years) | +1.40% |
| Revenue growth (last year) | -- |
| P/E ratio | NM |
| Price/Sales | -- |
| Price/Book | 170.01 |
Competitors
Data as of 4:00pm ET, 02/02/2023
Financials
| Next reporting date | February 27, 2023 |
| EPS forecast (this quarter) | -$1.12 |
| Annual revenue (last year) | $0.00 |
| Annual profit (last year) | -$130.4M |
| Net profit margin | -- |
Profile
Sector Health Technology |
Industry Biotechnology |
No executives to display |
Corporate headquarters New York, New York |
Forecasts
